MYC and neoplasm: Together, these in vitro results demonstrate that ARV@PDSA treatment not only facilitated the BRD4 degradation but also efficiently drugged the undruggable oncogene c‐Myc, again highlighting the promise of the Nano‐PROTACs strategy for anti‐tumor therapy.